Ajay Maker

Surgeon In Chief @UCSFCancer | Professor and Chief of Surgical Oncology @UCSFSurgery | tumor immunologist | Passionate about CRLM and IPMN | Loving Dad

[Ajay Maker @Maker_MD]

Honored to deliver the #JSGE Keynote Lecture at #jddw2026 in Kobe 🇯🇵. Grateful to President Prof. Unno’s generous hospitality and for the opportunity to engage with colleagues and friends on advancing surgical care and research. @RichSchulickMD @rajarnarayan #ShuichiAoki #JSGS

[Ajay Maker @Maker_MD]

Grateful to Prof. Satoi for the wonderful invitation to lecture at Kansai Medical University 🇯🇵Pancreatobiliary Surgery. A terrific opportunity to meet & exchange ideas on innovative approaches to PDAC and CRC liver metastases.🙏🏽 for warm hospitality & stimulating discussions!

[Paul Wong, MD @PaulWongMD]

New in @JournalofGISurg: How have IAP guidelines changed how we select IPMNs for surgery?🔪

Across 3 guideline eras, resected noninvasive cysts got bigger ⬆️(2.6>3cm) while invasive ones got smaller ⬇️(3.1>2.8cm) @Maker_MD @UCSFSurgery @BrighamSurgery

https://t.co/AGIvLUh1Or

[Ajay Maker @Maker_MD]

Congratulations Dr. Esserman! @UCSFSurgery #UCSFSurgOnc

[AIM-HI Accelerator Fund @aimhifund]

The AIM-HI Accelerator Fund is pleased to announce Laura Esserman, M.D., MBA, Director of the University of California, San Francisco (UCSF) Breast Care Center, as the recipient of the 2026 AIM-HI Beacon Award for Women Leaders in Oncology. Congratulations, Dr. Esserman! 🎉

[Ajay Maker @Maker_MD]

Honored & 🙏🏽 to receive the SSO Scholarship to the SUS Leadership Agility Program at @KelloggSchool of Management. Truly 🔥 executive leadership course with 💪🏽 faculty and colleagues from across academic surgery. Grateful to all who made this possible. @SocSurgOnc @UnivSurg

[Julie Hallet @HalletJulie]

Want to learn about options and decision-making for colorectal liver metastases?

Check out this paper from SSAT-SSO joint symposium at #DDW2026
including biology-guided systemic therapy, ctDNA, parenchymal preservation, ablation, transplant

📝 https://t.co/Y3LjRyU3iV

[Paul Wong, MD @PaulWongMD]

Check out our new paper on increased utilization of ITx in uveal melanoma liver metastases

Unlike cutaneous melanoma, use of ITx was NOT associated with improved survival. More liver directed therapies are needed 🔜
@Maker_MD @UCSFSurgery @BrighamSurgery

https://t.co/1FI1atSZ0r

[Ajay Maker @Maker_MD]

Deeply honored to be the Don Morton Visiting Professor and deliver his lectureship at @wvu_surgery. I hope we kept his discoveries alive discussing metastasectomy & immunotherapy. Incredibly impressed w/WVU 🔪 & 🔬 Grateful for incredible hospitality! @UCSFSurgery @UCSFHospitals

[Ajay Maker @Maker_MD]

A couple of times each 📆, I enjoy dinner with our clinical asst. professors. Always great to discuss clinical/research updates, share ideas and practices, & learn from one another. Grateful for their new ideas, programs, and energy moving #UCSFSurgOnc forward!

[Ajay Maker @Maker_MD]

Truly an honor to receive the @AmerSurg-European Surgical Association Exchange Award in Rome last week. 🙏🏽 to the leaders of both societies and gracious hosts at San Raffaele and Humanitas! 🇮🇹@Massimo04868945 @TorzilliGuido @StefanoCrippa6 @spartelli @lelecapurso #ESA2026

[Ajay Maker @Maker_MD]

@DDWMeeting @UCSFCancer @UCSFSurgery @VautheyMD @KennethTanabeMD @HalletJulie @edulundu @ryanwday @SSATNews @SocSurgOnc

[Ajay Maker @Maker_MD]

@DDWMeeting @UCSFCancer @UCSFSurgery Look fwd to great discussion & session today on treating and managing colorectal liver metastases - joint SSAT/SSO symposium at DDW with a fantastic panel of experts 💪✂️🦀@VautheyMD @KennethTanabeMD @HalletJulie @edulundu @ryanwday #michaelLi @SSATNews @SocSurgOnc @DDWMeeting

[Digestive Disease Week @DDWMeeting]

The liver isn’t just passive “soil” for cancer spread – it’s an active partner. Understanding its immune-tolerant environment could unlock new therapies for colorectal cancer metastases, says @Maker_MD of @UCSFCancer and @UCSFSurgery. #Oncology #DDW2026 #LiverTwitter

[Sophia Hernandez @SEHernandezz]

The Tissue is the Tissue at #AHPBA2026 @Maker_MD gave a fantastic talk on some of the innovative ways we are taking on the biology of cancer @UCSFSurgery and @UCSFCancer! Using our own immune system to fight against cancer is how we will get the job done 🧪

[Ajay Maker @Maker_MD]

@AHPBA

[Ajay Maker @Maker_MD]

👏🏼👏🏼👏🏼Congratulations to our many #UCSFSurgOnc trainees, fellows, and faculty for their outstanding contributions and presentations at #AHPBA2026 ! @UCSFSurgery @mohamedadamMD @HPB_Surgeon @SEHernandezz @LThornblade @stasinosmd @UCSFGSResidency @Lalehforoutani @paul_wongg

[Ajay Maker @Maker_MD]

Hot off the press❗️@JAMANetwork 💪. We teamed up with #Prenuvo to study elective screening MRIs in healthy asymptomatic individuals to establish the true prevalence of pancreatic cysts. Now we know 6-7% of the population has a cyst. >21% of 80+yo. #UCSFSurgOnc #IPMN @UCSFSurgery

[JAMA Network Open @JAMANetworkOpen]

Among 21,651 asymptomatic adults screened with MRI, 6.3% had incidental pancreatic cystic lesions, with <1% ≥3 cm; risk increased with age, female sex, and certain medical or family histories. #PancreaticCysts #MRI

https://t.co/f6rLi1wjND

[UCSF Surgery @UCSFSurgery]

‼️Dr. Ajay Maker (@Maker_MD) has been elected to the American Society for Clinical Investigation (@the_asci) — a peer-elected honor recognizing leaders in biomedical research — becoming only the second #surgeon-scientist from @UCSF elected to ASCI 👏

[Ajay Maker @Maker_MD]

Packed room 4 collaborative symposium b/t @sitcancer & @SocSurgOnc on Neoadjuvant Immunotherapy #SSO2026. This approach will shape the future of many cancers we manage. Grateful to plan with @EMittendorfMD @gmboland @SDownsCanner @JohnEMullinaxMD M.Lowe,S.Cohen,G.Beasley 👏🧬

[Ajay Maker @Maker_MD]

@SocSurgOnc Fantastic program and excited to host Deepa Magge at #UCSFSurgicalOncology @UCSFSurgery